Abstract
Artemisia sp., especially A. annua and A. afra, have been used for centuries to treat many ailments. While artemisinin is the main therapeutically active component, emerging evidence demonstrates that the other phytochemicals in this genus are also therapeutically active. Those compounds include flavonoids, other terpenes, coumarins, and phenolic acids. Artemisia sp. phytochemicals also improve bioavailability of artemisinin and synergistically improve artemisinin therapeutic efficacy, especially when delivered as dried leaf Artemisia as a tea infusion or as powdered dry leaves in a capsule or compressed into a tablet. Here results from in vitro, and in vivo animal and human studies are summarized and critically discussed for mainly malaria, but also other diseases susceptible to artemisinin and Artemisia sp. including schistosomiasis, leishmaniasis, and trypanosomiasis.
Similar content being viewed by others
Abbreviations
- ACT:
-
Artemisinin combination therapy
- ASAQ:
-
Artesunate and amodiaquine
- CQ:
-
Chloroquine
- DLA:
-
Dried leaf Artemisia
- EIF2α:
-
Eukaryotic translation initiation factor 2α
- ERK:
-
Extracellular signal-regulated kinases
- EOs:
-
Essential oils
- IC50 :
-
Half-maximal inhibitory concentration
- IkB-alpha:
-
Inhibitor of kappa B alpha
- IKK:
-
I kappa B kinase
- JNK:
-
c-Jun N-terminal kinases
- MAPK:
-
Mitogen-activated protein kinases
- NF-kB:
-
Nuclear factor kappa-light-chain-enhancer of activated B cells
- PI3P:
-
Phosphatidylinositol triphosphate
- PI3K:
-
Phosphatidylinositol-3-kinase
- PK4:
-
Protein kinase 4
- PZQ:
-
Praziquantel
- RSA:
-
Ring-stage survival assay
- TID:
-
ter in die, three times/day
- TNF-α:
-
Tumor necrosis factor alpha
- Ub:
-
Ubiquitin
- UPR:
-
Unfolded protein response
- WHO:
-
World Health Organization
References
Alin MH, Bjorkman A (1994) Concentration and time dependency of artemisinin efficacy against Plasmodium falciparum in vitro. Am J Trop Med Hyg 50:771–776
Argemi X, Hansmann Y, Gaudart J, Gillibert A, Caumes E, Jauréguiberry S, Meyer N (2019) Comment on “Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial”. Phytomedicine 62:152804
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D (2014) A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505:50–55
Berrizbeitia de Morgado M, Cariaco Sifontes Y, Imery Buiza J, Lutgen P (2017) Activity of Artemisia annua infusions on epimastigotes of Trypanosoma cruzi. Enferm Infecc Microbiol Clin 35:390–392
Birgersson S, Van Toi P, Truong NT, Dung NT, Ashton M, Hien TT, Abelö A, Tarning J (2016) Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers. Malar J 15:90
Bischoff O, Natalang E, Deplaine G, Proux C, Dillies MA, Sismeiro O, Guigon G, Bonnefoy S, Patarapotikul J, Mercereau-Puijalon O, Coppée JY, David PH (2008) Dynamic RNA profiling in Plasmodium falciparum synchronized blood stages exposed to lethal doses of artesunate. BMC Genom 9:388
Blaustein M, Pérez-Munizaga D, Sánchez MA, Urrutia C, Grande A, Risso G, Srebrow A, Alfaro J, Colman-Lerner A (2013) Modulation of the Akt pathway reveals a novel link with PERK/eIF2α, which is relevant during hypoxia. PLoS ONE 8:e69668
Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJ (2012) A major genome region underlying artemisinin resistance in malaria. Science 336:79–82
Clark IA, Budd AC, Alleva LM, Cowden WB (2006) Human malarial disease: a consequence of inflammatory cytokine release. Malar J 5:85
Cornet-Vernet L, Munyangi J, Chen L, Towler M, Weathers P (2019a) Response to Argemi et al. 2019. Phytomedicine 62:152943
Cornet-Vernet L, Munyangi J, Chen L, Towler M, Weathers P (2019b) Correspondence: response to Gillibert et al. 2019. Phytomedicine. In Press, Accepted Manuscript 152980
Czechowski T, Rinaldi MA, Famodimu MT, Van Veelen M, Larson TR, Winzer T, Rathbone DA, Harvey D, Horrocks P, Graham IA (2019) Flavonoid versus artemisinin anti-malarial activity in Artemisia annua whole-leaf extracts. Front Plant Sci 10:984
Daddy NB, Kalisya LM, Bagire PG, Watt RL, Towler MJ, Weathers PJ (2017) Artemisia annua dried leaf tablets treated malaria resistant to ACT and iv artesunate: case reports. Phytomedicine 32:37–40
Danis M, Buisson Y (2019) Tisane magique ou bouillon de onze heures? Bull Soc Pathol Exot 112:3–4
de Cássia da Silveira e Sá R, Andrade LN, de Sousa DP (2013) A review on anti-inflammatory activity of monoterpenes. Molecules 18:1227–1254
De Donno A, Grassi T, Idolo A, Guido M, Papadia P, Caccioppola A, Villanova L, Merendino A, Bagordo F, Fanizzi FP (2012) First-time comparison of the in vitro antimalarial activity of Artemisia annua herbal tea and artemisinin. Trans R Soc Trop Med Hyg 106:696–700
de Magalhães MP, Dupont I, Hendrickx A, Joly A, Raas T, Dessy S, Sergent T, Schneider YJ (2012) Anti-inflammatory effect and modulation of cytochrome P450 activities by Artemisia annua tea infusions in human intestinal Caco-2 cells. Food Chem 134:864–871
den Boer M, Argaw D, Jannin J, Alvar J (2011) Leishmaniasis impact and treatment access. Clin Microbiol Infect 17:1471–1477
Desrosiers MR, Weathers PJ (2016) Effect of leaf digestion and artemisinin solubility for use in oral consumption of dried Artemisia annua leaves to treat malaria. J Ethnopharmacol 190:313–318
Desrosiers MR, Weathers PJ (2018) Artemisinin permeability via Caco-2 cells increases after simulated digestion of Artemisia annua leaves. J Ethnopharmacol 210:254–259
Desrosiers MR, Towler MJ, Weathers PJ (2019) Artemisia annua and Artemisia afra essential oils and their therapeutic potential. In: Malik S (ed) Essential oil research. Springer, Cham, pp 197–209
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455–467
Duke SO, Paul RN (1993) Development and fine structure of the glandular trichomes of Artemisia annua L. Int J Plant Sci 154:107–118
Eastman RT, Fidock DA (2009) Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 7:864–874
Efferth T, Herrmann F, Tahrani A, Wink M (2011) Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Phytomedicine 18:959–969
Elfawal MA, Towler MJ, Reich NG, Golenbock D, Weathers PJ, Rich SM (2012) Dried whole plant Artemisia annua as an antimalarial therapy. PLoS ONE 7:e52746
Elfawal MA, Towler MJ, Reich NG, Weathers PJ, Rich SM (2015) Dried whole-plant Artemisia annua slows evolution of malaria drug resistance and overcomes resistance to artemisinin. Proc Natl Acad Sci USA 112:821–826
Erdman LK, Finney CAM, Liles WC, Kain KC (2008) Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity. Mol Biochem Parasitol 162(2):105–111
Ferreira JFS, Janick J (1995) Floral morphology of Artemisia annua with special reference to trichomes. Int J Plant Sci 156(6):807–815
Ferreira JF, Luthria DL, Sasaki T, Heyerick A (2010) Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer. Molecules 15:3135–3170
Fiamegos YC, Kastritis PL, Exarchou V, Han H, Bonvin AM, Vervoort J, Lewis K, Hamblin MR, Tegos GP (2011) Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS ONE 6:e18127
Food and Agricultural Organization of the UN (1986) Forestry paper 67: Some medicinal forest plants of Africa and Latin America. http://www.fao.org/docrep/015/an797e/an797e00.pdf. Accessed Dec 29, 2018
Ganesh D, Fuehrer HP, Starzengrüber P, Swoboda P, Khan WA, Reismann JA, Mueller MS, Chiba P, Noedl H (2012) Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones. Parasitol Res 110:2289–2295
Gathirwa JW, Rukunga GM, Njagi EN, Omar SA, Mwitari PG, Guantai AN, Tolo FM, Kimani CW, Muthaura CN, Kirira PG, Ndunda TN, Amalemba G, Mungai GM, Ndiege IO (2008) The in vitro anti-plasmodial and in vivo anti-malarial efficacy of combinations of some medicinal plants used traditionally for treatment of malaria by the Meru community in Kenya. J Ethnopharmacol 115:223–231
Gbotosho GO, Sowunmi A, Okuboyejo TM, Happi CT (2012) Oral artesunate–amodiaquine and artemether–lumefantrine in the treatment of uncomplicated hyperparasitaemic Plasmodium falciparum malaria in children. J Trop Pediatr 58:151–153
Gillibert A, Jauréguiberry S, Hansmann Y, Argemi X, Landier J, Caumes E, and Gaudart J (2019) Comment on “A. annua and A. afra infusions vs Artesunate–amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial”. Phytomedicine In Press, Accepted Manuscript: 152981
Gordi T, Hai TN, Hoai NM, Thyberg M, Ashton M (2000) Use of saliva and capillary blood samples as substitutes for venous blood sampling in pharmacokinetic investigations of artemisinin. Eur J Clin Pharmacol 56:561–566
Grace MH, Lategan C, Graziose R, Smith PJ, Raskin I, Lila MA (2012) Antiplasmodial activity of the ethnobotanical plant Cassia fistula. Nat Prod Commun 7:1263–1266
He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z (2015) Curcumin, inflammation, and chronic diseases: how are they linked? Molecules 20:9183–9213
Hien TT, Hanpithakpong W, Truong NT, Dung NT, Toi PV, Farrar J, Lindegardh N, Tarning J, Ashton M (2011) Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover study. Clin Ther 33:644–654
Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, Katan MB (1997) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418:152–156
Jessing KK, Cedergreen N, Jensen J, Hansen HCB (2009) Degradation and ecotoxicity of the biomedical drug artemisinin in soil. Environ Chem 28(4):701–710
Jin H, Xu Z, Cui K, Zhang T, Lu W, Huang J (2014) Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II. Fitoterapia 94:55–61
Juergens UR, Engelen T, Racké K, Stöber M, Gillissen A, Vetter H (2004) Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. Pulm Pharmacol Ther 17:281–287
Keiser J, Utzinger J (2012) Antimalarials in the treatment of schistosomiasis. Curr Pharm Des 18:3531–3538
Kim WS, Choi WJ, Lee S, Kim WJ, Lee DC, Sohn UD, Shin HS, Kim W (2015) Anti-inflammatory, antioxidant and antimicrobial effects of artemisinin extracts from Artemisia annua L. Korean J Physiol Pharmacol 19:21–27
Kohlert C, van Rensen I, März R, Schindler G, Graefe EU, Veit M (2000) Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans. Planta Med 66:495–505
Kraft C, Jenett-Siems K, Siems K, Jakupovic J, Mavi S, Bienzle U, Eich E (2003) In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe. Phytother Res 17:123–128
Lagarce L, Lerolle N, Asfar P, Le Govic Y, Lainé-Cessac P, de Gentile L (2016) A non-pharmaceutical form of Artemisia annua is not effective in preventing Plasmodium falciparum malaria. J Travel Med 23(5):1–3
Lehane AM, Saliba KJ (2008) Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite. BMC Res Notes 1:26
Li YJ, Guo Y, Yang Q, Weng XG, Yang L, Wang YJ, Chen Y, Zhang D, Li Q, Liu XC, Kan XX, Chen X, Zhu XX, Kmoníèková E, Zídek Z (2015) Flavonoids casticin and chrysosplenol D from Artemisia annua L inhibit inflammation in vitro and in vivo. Toxicol Appl Pharmacol 286:151–158
Li J, Zhang C, Gong M, Wang M (2018) Combination of artemisinin-based natural compounds from Artemisia annua L for the treatment of malaria: pharmacodynamic and pharmacokinetic studies. Phytother Res 32:1415–1420
Liu KC, Yang SL, Roberts MF, Elford BC, Phillipson JD (1992) Antimalarial activity of Artemisia annua flavonoids from whole plants and cell cultures. Plant Cell Rep 11:637–640
Liu NQ, Cao M, Frédérich M, Choi YH, Verpoorte R, van der Kooy F (2010) Metabolomic investigation of the ethnopharmacological use of Artemisia afra with NMR spectroscopy and multivariate data analysis. J Ethnopharmacol 128:230–235
Lubbe A, Seibert I, Klimkait T, van der Kooy F (2012) Ethnopharmacology in overdrive: the remarkable anti-HIV activity of Artemisia annua. J Ethnopharmacol 141:854–859
Lwin KM, Phyo AP, Tarning J, Hanpithakpong W, Ashley EA, Lee SJ, Cheah P, Singhasivanon P, White NJ, Lindegårdh N, Nosten F (2012) Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria. Antimicrob Agents Chemother 56:1571–1577
Malik A, Kushnoor A, Saini V, Singhal S, Kumar S, Yadav YC (2011) In vitro antioxidant properties of scopoletin. J Chem Pharm Res 3:659–665
Mbengue A, Bhattacharjee S, Pandharkar T, Liu H, Estiu G, Stahelin RV, Rizk SS, Njimoh DL, Ryan Y, Chotivanich K, Nguon C, Ghorbal M, Lopez-Rubio JJ, Pfrender M, Emrich S, Mohandas N, Dondorp AM, Wiest O, Haldar K (2015) A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 520:683–687
McDougall B, King PJ, Wu BW, Hostomsky Z, Reinecke MG, Robinson WE (1998) Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. Antimicrob Agents Chemother 42:140–146
Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos MD, Cao J, Chen JH, Collet L, Cui L, Thakur GD, Dieye A, Djallé D, Dorkenoo MA, Eboumbou-Moukoko CE, Espino FE, Fandeur T, Ferreira-da-Cruz MF, Fola AA, Fuehrer HP, Hassan AM, Herrera S, Hongvanthong B, Houzé S, Ibrahim ML, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner PG, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati JB, Ménard S, Morlais I, Muhindo-Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo JB, Pillai DR, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué KD, Sirima SB, Sutherland C, Syafruddin D, Tahar R, Tang LH, Touré OA, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale JC, Stokes B, Straimer J, Witkowski B, Fidock DA, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O, KARMA Consortium (2016) A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med 374:2453–2464
Mesa LE, Vasquez D, Lutgen P, Vélez ID, Restrepo AM, Ortiz I, Robledo SM (2017) In vitro and in vivo antileishmanial activity of Artemisia annua L. leaves powder and its potential usefulness in the treatment of uncomplicated cutaneous leishmaniasis in humans. Rev Soc Bras Med Trop 50:52–60
Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, Chotivanich K, Imwong M, Pukrittayakamee S, Dhorda M, Nguon C, Lim P, Amaratunga C, Suon S, Hien TT, Htut Y, Faiz MA, Onyamboko MA, Mayxay M, Newton PN, Tripura R, Woodrow CJ, Miotto O, Kwiatkowski DP, Nosten F, Day NP, Preiser PR, White NJ, Dondorp AM, Fairhurst RM, Bozdech Z (2015) Drug resistance population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science 347:431–435
Moriyasu T, Nakamura R, Deloer S, Senba M, Kubo M, Inoue M, Culleton R, Hamano S (2018) Schistosoma mansoni infection suppresses the growth of Plasmodium yoelii parasites in the liver and reduces gametocyte infectivity to mosquitoes. PLoS Negl Trop Dis 12(1):e0006197. https://doi.org/10.1371/journal.pntd.0006197
Moura IC, Wunderlich G, Uhrig ML, Couto AS, Peres VJ, Katzin AM, Kimura EA (2001) Limonene arrests parasite development and inhibits isoprenylation of proteins in Plasmodium falciparum. Antimicrob Agents Chemother 45:2553–2558
Mouton J, Jansen O, Frédérich M, van der Kooy F (2013) Is artemisinin the only antiplasmodial compound in the Artemisia annua tea infusion? An in vitro study. Planta Med 79:468–470
Moyo P, Botha ME, Nondaba S, Niemand J, Maharaj VJ, Eloff JN, Louw AI, Birkholtz L (2016) In vitro inhibition of Plasmodium falciparum early and late stage gametocyte viability by extracts from eight traditionally used South African plant species. J Ethnopharmacol 185:235–242
Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P (2018) Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial. Phytomedicine 51:233–240
Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P (2019) Artemisia annua and Artemisia afra tea infusions vs artesunate–amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial. Phytomedicine 57:49–56
Naß J, Efferth T (2018) The activity of Artemisia spp and their constituents against trypanosomiasis. Phytomedicine 47:184–191
Naß J, Efferth T (2019) Development of artemisinin resistance in malaria therapy. Pharmacol Res 146:104275. https://doi.org/10.1016/j.phrs.2019.104275
Niaré K, Dara A, Sagara I, Sissoko MS, Guindo CO, Cissé NH, Coulibaly CO, Ringwald P, Benoit-Vical F, Berry A, Djimdé AA, Doumbo OK (2016) In vivo efficacy and parasite clearance of artesunate + sulfadoxine-pyrimethamine versus artemether–lumefantrine in Mali. Am J Trop Med Hyg 94:634–639
Ogwang PE, Ogwal JO, Kasasa S, Ejobi F, Kabasa D, Obua C (2011) Use of Artemisia annua L. infusion for malaria prevention: mode of action and benefits in a Ugandan community. Br J Pharm Res 1:e124–e132
Ogwang PE, Ogwal JO, Kasasa S, Olila D, Ejobi F, Kabasa D, Obua C (2012) Artemisia annua L. infusion consumed once a week reduces risk of multiple episodes of malaria: a randomised trial in a Ugandan community. Trop J Pharm Res 11:445–453
Packard RM (2014) The origins of antimalarial-drug resistance. N Engl J Med 371:397–399
Paloque L, Ramadani AP, Mercereau-Puijalon O, Augereau JM, Benoit-Vical F (2016) Plasmodium falciparum: multifaceted resistance to artemisinins. Malar J 15:149
Penna-Coutinho J, Aguiar AC, Krettli AU (2018) Commercial drugs containing flavonoids are active in mice with malaria and in vitro against chloroquine-resistant Plasmodium falciparum. Mem Inst Oswaldo Cruz 113:e180279
Petersen I, Eastman R, Lanzer M (2011) Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett 585:1551–1562
Rath K, Taxis K, Walz G, Gleiter CH, Li SM, Heide L (2004) Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (Annual Wormwood). Am J Trop Med Hyg 70:128–132
Rathee P, Chaudhary H, Rathee S, Rathee D, Kumar V, Kohli K (2009) Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm Allergy Drug Targets 8:229–235
Rocamora F, Zhu L, Liong KY, Dondorp A, Miotto O, Mok S, Bozdech Z (2018) Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. PLoS Pathog 14:e1006930
Rodrigues-Goulart H, Kimura EA, Peres VJ, Couto AS, Aquino-Duarte FA, Katzin AM (2004) Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. Antimicrob Agents Chemother 48:2502–2509
Serafini M, Peluso I, Raguzzini A (2010) Antioxidants and the immune system: flavonoids as anti-inflammatory agents. Proc Nutr Soc 69:273–278
Shi C, Li H, Yang Y, Hou L (2015) Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives. Med Inflamm 2015:435713
Silva LF, Magalhães PM, Costa MR, Alecrim M, Chaves FC, Hidalgo AF, Pohlit AM, Vieira PP (2012) In vitro susceptibility of Plasmodium falciparum Welch field isolates to infusions prepared from Artemisia annua L. cultivated in the Brazilian Amazon. Mem Inst Oswaldo Cruz 107:859–866
Simonnet X, Grogg A F, Cutler M, Bathurst I (2009) Artemisia annua L. drying and storage. Artemisinin Forum 2008-joint meeting on ensuring sustainable artemisinin production: meeting global demand. Guilin, China, 24–26 November 2008
Sowunmi A, Akano K, Ntadom G, Ayede A, Oguche S, Agomo C, Okafor H, Watila I, Meremikwu M, Ogala W, Agomo P, Adowoye E, Fatunmbi B, Aderoyeje T, Happi C, Gbotosho G, Folarin O (2017) Anaemia following artemisinin-based combination treatments of uncomplicated Plasmodium falciparum malaria in children: temporal patterns of haematocrit and the use of uncomplicated hyperparasitaemia as a model for evaluating late-appearing anaemia. Chemotherapy 62:231–238
Spagnuolo C, Moccia S, Russo GL (2018) Anti-inflammatory effects of flavonoids in neurodegenerative disorders. Eur J Med Chem 153:105–115
Straimer J, Gnädig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, Dacheux M, Khim N, Zhang L, Lam S, Gregory PD, Urnov FD, Mercereau-Puijalon O, Benoit-Vical F, Fairhurst RM, Ménard D, Fidock DA (2015) Drug resistance K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347:428–431
Su V, King D, Woodrow I, McFadden G, Gleadow R (2008) Plasmodium falciparum growth is arrested by monoterpenes from eucalyptus oil. Flavor Fragr J 23:315–318
Suberu JO, Gorka AP, Jacobs L, Roepe PD, Sullivan N, Barker GC, Lapkin AA (2013) Anti-plasmodial polyvalent interactions in Artemisia annua L. aqueous extract—possible synergistic and resistance mechanisms. PLoS ONE 8:e80790
Svensson US, Ashton M (1999) Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br J Clin Pharmacol 48:528–535
Tasdemir D, Lack G, Brun R, Rüedi P, Scapozza L, Perozzo R (2006) Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J Med Chem 49:3345–3353
Tchandema CK, Lutgen P (2016) In vivo trials on the therapeutic effects of encapsulated Artemisia annua and Artemisia afra. Global J Res Anal 5(6):228–234
Tellez MR, Camilo C, Rimando AM, Duke SO (1999) Differential accumulation of isoprenoids in glanded and glandless Artemisia annua L. Phytochemistry 52(6):1035–1040
Titulaer HA, Zuidema J, Kager PA, Wetsteyn JC, Lugt CB, Merkus FW (1990) The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharm Pharmacol 42:810–813
Van der Kooy F, Sullivan SE (2013) The complexity of medicinal plants: the traditional Artemisia annua formulation, current status and future perspectives. J Ethnopharmacol 150:1–13
Van der Kooy F, Verpoorte R (2011) The content of artemisinin in the Artemisia annua tea infusion. Planta Medica 77:1754–1756
Van Zyl R, Seatlholo S, Van Vuuren S, Viljoen A (2006) The biological activities of 20 nature identical essential oil constituents. J Essent Oils Res 18:e129–e133
Vickers CE, Possell M, Cojocariu CI, Velikova VB, Laothawornkitkul J, Ryan A, Mullineaux PM, Nicholas Hewitt C (2009) Isoprene synthesis protects transgenic tobacco plants from oxidative stress. Plant Cell Environ 32:520–531
Wang Z, Wang Y, Cabrera M, Zhang Y, Gupta B, Wu Y, Kemirembe K, Hu Y, Liang X, Brashear A, Shrestha S, Li X, Miao J, Sun X, Yang Z, Cui L (2015) Artemisinin resistance at the China–Myanmar border and association with mutations in the K13 propeller gene. Antimicrob Agents Chemother 59:6952–6959
Wang KS, Li J, Wang Z, Mi C, Ma J, Piao LX, Xu GH, Li X, Jin X (2017) Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways. Immunopharmacol Immunotoxicol 39:28–36
Weathers PJ, Towler MJ (2014) Changes in key constituents of clonally propagated Artemisia annua L. during preparation of compressed leaf tablets for possible therapeutic use. Ind Crops Prod 62:173–178
Weathers PJ, Arsenault PR, Covello PS, McMickle A, Teoh KH, Reed DW (2011) Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseases. Phytochem Rev 10:173–183
Weathers PJ, Towler M, Hassanali A, Lutgen P, Engeu PO (2014a) Dried-leaf Artemisia annua: a practical malaria therapeutic for developing countries? World J Pharmacol 3:39–55
Weathers PJ, Elfawal MA, Towler MJ, Acquaah-Mensah GK, Rich SM (2014b) Pharmacokinetics of artemisinin delivered by oral consumption of Artemisia annua dried leaves in healthy vs. Plasmodium chabaudi-infected mice. J Ethnopharmacol 153:732–736
Weathers PJ, Cambra HM, Desrosiers MR, Rassias D, Towler MJ (2017) Artemisinin the noble molecule: from plant to patient. Stud Nat Prod Chem 52:193–229
Wei S, Ji H, Yang B, Ma L, Bei Z, Li X, Dang H, Yang X, Liu C, Wu X, Chen J (2015) Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome. Malar J 14:432
Willcox M, Bodeker G, Bourdy G, Dhingra V, Falquet J, Ferreira JFS, Graz B, Hirt H-M, Hsu E, de Magalhães P, Provendier D, Wright C (2004) Artemisia annua as a traditional herbal antimalarial. In: Willcox ML, Bodeker G, Rasoanaivo P (eds) Traditional medicinal plants and malaria. CRC Press, Boca Raton, pp 43–59
Witkowski B, Lelièvre J, Barragán MJ, Laurent V, Su XZ, Berry A, Benoit-Vical F (2010) Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother 54:1872–1877
Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D (2013) Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother 57:914–923
World Health Organization (2000) General guidelines for methodologies on research and evaluation of traditional medicine. http://apps.who.int/iris/bitstream/handle/10665/66783/WHO_EDM_TRM_2000.1.pdf;jsessionid=58426E99-AFB3D5CEDC7DF3E3686E4D87?sequence=1
World Health Organization (2012) Effectiveness of non-pharmaceutical forms of Artemisia annua L. against malaria. https://www.hoint/malaria/position_statement_herbal_remedy_artemWoSa_annua_lpdf. Cited 27 Dec 2018
World Health Organization (2014) Emergence and spread of artemisinin resistance calls for intensified efforts to withdraw oral artemisinin-based monotherapy from the market. https://www.who.int/malaria/publications/atoz/oral-artemisinin-based-monotherapies-1may2014.pdf?ua=1. Cited June 25, 2019
World Health Organization (2017) Artemisinin and artemisinin-based combination therapy resistance-April 2017. http://apps.who.int/iris/bitstream/handle/10665/255213/WHO-HTM-GMP-2017.9-eng.pdf?sequence=1. Cited 27 Dec 2018
World Health Organization (2018a) Leishmaniasis. https://www.hoint/news-room/fact-sheets/detail/leishmaniasis. Cited 27 Dec 2018
World Health Organization (2018b) Schistosomiasis. https://www.hoint/news-room/fact-sheets/detail/schistosomiasis. Cited 27 Dec 2018
Yun C, Jung Y, Chun W, Yang B, Ryu J, Lim C, Kim JH, Kim H, Cho SI (2016) Anti-inflammatory effects of Artemisia leaf extract in mice with contact dermatitis in vitro and in vivo. Med Inflamm 2016:8027537
Zaid O, Abd MR, Hasidah M, Sabariah M, Rahi S, Basir R (2016) Antiplasmodial and chloroquine chemosensitizing and resistance reversal effects of coumarin derivatives against Plasmodium falciparum 3D7 and K1. Trop Biomed 33:14–26
Zhang M, Gallego-Delgado J, Fernandez-Arias C, Waters NC, Rodriguez A, Tsuji M, Wek RC, Nussenzweig V, Sullivan WJ (2017) Inhibiting the plasmodium eIF2α Kinase PK4 prevents artemisinin-induced latency. Cell Host Microbe 22:766–776
Zhu C, Xiong Z, Chen X, Peng F, Hu X, Chen Y, Wang Q (2012) Artemisinin attenuates lipopolysaccharide-stimulated proinflammatory responses by inhibiting NF-κB pathway in microglia cells. PLoS ONE 7:e35125
Acknowledgements
Authors thank Impala Avenir Foundation, Mme Héléne de Cossé Brissac, Mr. Jean-Louis Bouchard, and the Ararat Fund at WPI for generously funding some of the studies herein. We are also grateful for Award Number NIH-2R15AT008277-02 from the National Center for Complementary and Integrative Health that enabled PJW, MD and MJT for funding artemisinin bioavailability studies, and phytochemical analyses of the plant material used in treating patients. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary and Integrative Health or the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gruessner, B.M., Cornet-Vernet, L., Desrosiers, M.R. et al. It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis. Phytochem Rev 18, 1509–1527 (2019). https://doi.org/10.1007/s11101-019-09645-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11101-019-09645-9